Construction and characterization of a stable subgenomic replicon system of a Brazilian dengue virus type 3 strain (BR DEN3 290-02)
- PMID: 19761796
- DOI: 10.1016/j.jviromet.2009.09.004
Construction and characterization of a stable subgenomic replicon system of a Brazilian dengue virus type 3 strain (BR DEN3 290-02)
Abstract
Dengue viruses (DENV) cause the most common arboviral disease afflicting men. Clinical manifestations range from asymptomatic to dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). The mechanisms involved in the disease pathogenesis are not fully understood. The severity of the disease seems to be influenced by both viral and host factors. Subgenomic replicons of DENV can be used to study viral replication mechanisms and evaluate the effects of antiviral drugs on viral replication. The objective was to generate and characterize biologically a replicon from a clinical isolate of DENV-3, as part of our studies to understand how this new isolate interacts with cells. To obtain this replicon several RT-PCR fragments encoding the non-structural proteins genes were cloned in high-copy vectors, and used to assemble the replicon in a BAC plasmid vector containing a synthetic DNA molecule encoding the 5' and 3' ends of a viral cDNA with a T7 DNA-dependent RNA polymerase promoter and a ribozyme. In vitro transcribed RNA recovered from this BAC plasmid was transfected into C6/36 mosquito cells, and dengue virus protein expression was assessed by indirect immunofluorescence using polyclonal antibodies. The results showed that the replicon was replicated efficiently in cells, demonstrating successful assembly of a DENV-3 replicon.
Similar articles
-
Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2.J Biomed Sci. 2008 Jan;15(1):15-27. doi: 10.1007/s11373-007-9204-0. Epub 2007 Aug 31. J Biomed Sci. 2008. PMID: 17768670
-
Construction and characterization of subgenomic replicons of New York strain of West Nile virus.Virology. 2002 May 10;296(2):219-33. doi: 10.1006/viro.2002.1453. Virology. 2002. PMID: 12069521
-
Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.Antiviral Res. 2013 May;98(2):228-41. doi: 10.1016/j.antiviral.2013.03.001. Epub 2013 Mar 13. Antiviral Res. 2013. PMID: 23499649
-
Establishment and Application of Flavivirus Replicons.Adv Exp Med Biol. 2018;1062:165-173. doi: 10.1007/978-981-10-8727-1_12. Adv Exp Med Biol. 2018. PMID: 29845532 Review.
-
Dengue Virus Reporter Replicon is a Valuable Tool for Antiviral Drug Discovery and Analysis of Virus Replication Mechanisms.Viruses. 2016 May 5;8(5):122. doi: 10.3390/v8050122. Viruses. 2016. PMID: 27164125 Free PMC article. Review.
Cited by
-
The citrus flavanone naringenin impairs dengue virus replication in human cells.Sci Rep. 2017 Feb 3;7:41864. doi: 10.1038/srep41864. Sci Rep. 2017. PMID: 28157234 Free PMC article.
-
Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2.Virol J. 2013 Feb 26;10:64. doi: 10.1186/1743-422X-10-64. Virol J. 2013. PMID: 23442449 Free PMC article.
-
Quinic acid derivatives inhibit dengue virus replication in vitro.Virol J. 2015 Dec 22;12:223. doi: 10.1186/s12985-015-0443-9. Virol J. 2015. PMID: 26695767 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical